← 홈

Antibody · TNF-α

155개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 155개
AntibodystaleJanssenApproved

adalimumab (Humira, Infliximab Adalimumab y Golimumab)

Ulcerative Colitis; Thromboembolism · Ulcerative Colitis

#UlcerativeColitis#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

Infliximab CT-P13 (Infliximab CT-P13)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

Infliximab Control (Infliximab Control)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenApproved

Infliximab Dose Intensification (Infliximab Dose Intensification)

Crohn Disease (CD) · Crohn Disease (CD)

#CrohnDiseaseCD#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

Infliximab Increased Dose (Infliximab Increased Dose)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab Increased Frequency (Infliximab Increased Frequency)

Rheumatoid Arthritis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 1

Infliximab Treatment (Infliximab Treatment)

Ulcerative Colitis Chronic Moderate; Ulcerative Colitis Chronic Severe · Ulcerative Colitis Chronic Moderate

#UlcerativeColitisChronicModerate#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 2

Infliximab and Basiliximab (Infliximab and Basiliximab)

Graft Versus Host Disease; Steroid Refractory GVHD · FRα

#FR#Antibody#Phase2#항체#면역항체+4
효능 ORR 10%임상시험 1상태 DISCONTINUED
AntibodystaleJanssenApproved

Infliximab and MTX (Infliximab and MTX)

Ankylosing Spondylitis · Ankylosing Spondylitis

#AnkylosingSpondylitis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Infliximab and immunosuppressives (Infliximab and immunosuppressives)

Crohn Disease; Infliximab · Crohn Disease

#CrohnDisease#Antibody#Approved#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

Infliximab and methotrexate (Infliximab and methotrexate)

Psoriasis · Psoriasis

#Psoriasis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab at weeks 0 and 8 (Infliximab at weeks 0 and 8)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab at weeks 0,2, and 6 (Infliximab at weeks 0,2, and 6)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPhase 3

Infliximab at weeks 0,4, and 8 (Infliximab at weeks 0,4, and 8)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleJanssenPreclinical

Infliximab combined with azathioprine therapy (Infliximab combined with azathioprine therapy)

Crohn's Diseases; Crohn's Disease in Pediatric Patient · Crohn's Diseases

#CrohnsDiseases#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenPreclinical

Infliximab group (Infliximab group)

Rheumatoid Arthritis（RA） · Rheumatoid Arthritis（RA）

#RheumatoidArthritisRA#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPreclinical

Infliximab monotherapy (Infliximab monotherapy)

Crohn's Diseases; Crohn's Disease in Pediatric Patient · Crohn's Diseases

#CrohnsDiseases#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenApproved

ustekinumab (Stelara, Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib)

Inflammatory Bowel Diseases; Crohn Disease · Inflammatory Bowel Diseases

#InflammatoryBowelDiseases#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

Infliximab plus methotrexate (Infliximab plus methotrexate)

Juvenile Idiopathic Arthritis · Juvenile Idiopathic Arthritis

#JuvenileIdiopathicArthritis#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

Infliximab precision dosing (Infliximab precision dosing)

Crohn Disease · Crohn Disease

#CrohnDisease#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED

5 / 8 페이지

← 이전다음 →